Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-03 Purchase | 2024-10-21 8:22 pm | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 922 | $11.33 | $10,447 | 922 (Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:24 pm | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 16,041 | $4.7363 | $75,975 | 236,771 (Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:24 pm | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 10,834 | $4.7363 | $51,313 | 126,382 (Direct) | View |
| 2024-03-12 Sale(A) | 2024-04-17 4:12 pm | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 11,537 | $3.164 | $36,503 | 252,812 (Direct) | View |
| 2024-03-11 Sale(A) | 2024-04-17 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 13,201 | $3.4064 | $44,968 | 130,154 (Direct) | View |
| 2024-04-04 Purchase | 2024-04-08 5:32 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 177,993 | $4.6848 | $833,867 | 9,275,851 (Indirect) | View |
| 2024-04-01 Purchase | 2024-04-03 5:22 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 504,272 | $3.8362 | $1,934,505 | 9,097,858 (Indirect) | View |
| 2024-03-11 Sale | 2024-03-12 8:07 pm | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 13,201 | $3.4064 | $44,968 | 372,979 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 8:04 pm | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 29,768 | $3.3125 | $98,605 | 649,156 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-12 8:01 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 183,238 | $3.1694 | $580,760 | 2,552,499 (Direct) | View |
| 2023-10-16 Sale | 2023-10-18 5:15 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2,756,499 | $1.6156 | $4,453,308 | 8,593,586 (Indirect) | View |
| 2022-08-09 Purchase | 2022-08-11 4:08 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 115,000 | $7.5457 | $867,750 | 11,350,085 (Indirect) | View |
| 2022-08-08 Purchase | 2022-08-10 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 97,000 | $7.24 | $702,280 | 11,235,085 (Indirect) | View |
| 2022-08-05 Purchase | 2022-08-09 4:08 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 141,000 | $6.95 | $979,950 | 11,138,085 (Indirect) | View |
| 2022-08-04 Purchase | 2022-08-08 4:09 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 95,100 | $6.17 | $586,767 | 10,997,085 (Indirect) | View |
| 2022-08-03 Purchase | 2022-08-05 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 100,000 | $5.84 | $584,000 | 10,901,985 (Indirect) | View |
| 2022-08-02 Purchase | 2022-08-04 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 412,406 | $5.59 | $2,305,350 | 10,801,985 (Indirect) | View |
| 2022-08-01 Purchase | 2022-08-03 5:16 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 144,185 | $5.05 | $728,134 | 10,389,579 (Indirect) | View |
| 2022-07-29 Purchase | 2022-08-02 4:27 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 222,123 | $5.03 | $1,117,279 | 10,245,394 (Indirect) | View |
| 2022-07-28 Purchase | 2022-08-01 5:37 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 119,392 | $5 | $596,960 | 10,023,271 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-04 Option Award | 2024-06-06 4:15 pm | N/A 2034-06-03 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 51,915 | $0 | 51,915 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:13 pm | N/A 2034-06-03 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 46,706 | $0 | 46,706 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:12 pm | N/A 2034-06-03 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 42,018 | $0 | 42,018 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:12 pm | N/A 2034-06-03 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 42,018 | $0 | 42,018 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:12 pm | N/A 2034-06-03 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 45,664 | $0 | 45,664 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:06 pm | N/A 2034-06-03 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 46,359 | $0 | 46,359 (Direct) | View |
| 2024-03-09 Option Award | 2024-03-12 8:07 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 252,280 | $0 | 372,979 (Direct) | View |
| 2024-03-09 Option Award | 2024-03-12 8:04 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 405,450 | $0 | 649,156 (Direct) | View |
| 2024-03-09 Option Award | 2024-03-12 8:01 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 1,081,201 | $0 | 2,552,499 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-11 5:42 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 273,058 | $0 | 1,654,536 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-11 5:42 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 273,058 | $0.552 | 1,654,536 (Direct) | View |
| 2023-09-07 Tax Withholding | 2023-09-11 5:42 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 73,807 | $7.22 | 1,654,536 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-11 4:31 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 5,437 | $0 | 14,812 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-11 4:31 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 5,437 | $0.552 | 14,812 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 4:13 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 9,604 | $0 | 15,854 (Direct) | View |
| 2023-08-22 Exercise | 2023-08-24 4:13 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 9,604 | $0.552 | 15,854 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 5:46 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 24,606 | $0 | 24,606 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 5:43 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 24,423 | $0 | 24,423 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 5:42 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 22,137 | $0 | 22,137 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 5:34 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 24,058 | $0 | 24,058 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 5:32 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 27,350 | $0 | 27,350 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 5:30 pm | N/A 2033-06-29 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 22,137 | $0 | 22,137 (Direct) | View |
| 2023-06-27 Exercise | 2023-06-29 4:23 pm | N/A 2023-09-07 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 9,604 | $0 | 28,248 (Direct) | View |
| 2023-06-27 Exercise | 2023-06-29 4:23 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 9,604 | $0.552 | 28,248 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:27 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 220,258 | $0 | 220,258 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:25 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 110,028 | $0 | 110,028 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:22 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 488,750 | $0 | 1,705,285 (Direct) | View |